Year-end Sale % OFF 
Abstract
1. 1. Sutilains (Travase) enzymatic debridement has been evaluated in the non-infected and the Pseudomonas-infected experimental burn wound. 2. 2. Sutilains (Travase) would seem to predispose to burn wound sepsis in all the experimental circumstances evaluated. 3. 3. The incorporation of Sulfamylon or silver sulfadiazine 1% with sutilains did not protect against burn wound sepsis and death. 4. 4. Caution in clinical use of sutilains in the contaminated burn wound seems indicated by these data.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
